Category Archives: U.S. Policy and Funding

Global Health 2014: Top 10 stories in HIV, TB around the world

By on .

Ebola – Why is Ebola one of the top 10 stories in HIV and TB globally? Because the current crisis in West Africa echoes the history of those epidemics, highlights weaknesses that will continue to dog ongoing work to conquer those epidemics, and has once again shown that neglecting infectious disease anywhere poses a threat […]

Gilead hepatitis C drug price deal leaves global treatment access advocates underwhelmed

By on .

When the U.S. Food and Drug Administration approved sofosbuvir for the treatment of chronic hepatitis C in early December, it was a step that was “expected to dramatically improve outcomes for many patients,” as one report put it. But how many was a big question, as we noted here. While the drug shortens treatment for […]